Metabolic syndrome is co-occurrence of obesity, insulin resistance, atherogenic
dyslipidemia (high triglyceride, low high density lipoprotein cholesterol), and hypertension. It …

Insulin resistance and the metabolic syndrome are complex metabolic traits and key risk
factors for the development of cardiovascular disease. They result from the interplay of …

Obesity is reaching epidemic proportions with recent worldwide figures estimated at 1.4
billion and rising year‐on‐year. Obesity affects all socioeconomic backgrounds and …

Until just a few years ago, the genetic determinants of obesity and metabolic syndrome were
largely unknown, with the exception of a few forms of monogenic extreme obesity. Since …

Obesity, particularly central adiposity, is the primary causal factor in the development of
insulin resistance, the hallmark of the metabolic syndrome (MetS), a common condition …

Several candidate gene studies on the metabolic syndrome (MetS) have been conducted.
However, for most single nucleotide polymorphisms (SNPs) no systematic review on their …

Metabolic syndrome (MetS) is characterized by increased pro-oxidative stress and a pro-
inflammatory state. Several studies emphasized the protective effect of the Mediterranean …

Metabolic syndrome (MetS) is a cluster of metabolic traits associated with an increased risk
of cardiovascular disease and type 2 diabetes mellitus. Central obesity and insulin …

In the past few decades, the incidence of thyroid cancer (TC), namely of its papillary
hystotype (PTC), has shown a steady increase worldwide, which has been attributed at least …

Metabolic syndrome (MetS) is a complex disorder characterized by abdominal obesity,
elevated blood pressure, hyperlipidemia, and elevated fasting blood glucose levels. The …